BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 31384871)

  • 21. A facile synthesis, in vitro and in vivo MR studies of d-glucuronic acid-coated ultrasmall Ln₂O₃ (Ln = Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent.
    Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Lee JJ; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
    ACS Appl Mater Interfaces; 2011 Sep; 3(9):3325-34. PubMed ID: 21853997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
    Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA
    Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents.
    Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
    Biomaterials; 2012 Apr; 33(11):3254-61. PubMed ID: 22277624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent.
    Zhu D; White RD; Hardy PA; Weerapreeyakul N; Sutthanut K; Jay M
    J Nanosci Nanotechnol; 2006 Apr; 6(4):996-1003. PubMed ID: 16736756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 230/115 GHz Electron Paramagnetic Resonance/Double Electron-Electron Resonance Spectroscopy.
    Cho FH; Stepanov V; Abeywardana C; Takahashi S
    Methods Enzymol; 2015; 563():95-118. PubMed ID: 26478483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of agglomeration on the relaxometric properties of paramagnetic ultra-small gadolinium oxide nanoparticles.
    Faucher L; Gossuin Y; Hocq A; Fortin MA
    Nanotechnology; 2011 Jul; 22(29):295103. PubMed ID: 21693804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation on NMR relaxivity of nano-sized cyano-bridged coordination polymers.
    Perrier M; Kenouche S; Long J; Thangavel K; Larionova J; Goze-Bac C; Lascialfari A; Mariani M; Baril N; Guérin C; Donnadieu B; Trifonov A; Guari Y
    Inorg Chem; 2013 Dec; 52(23):13402-14. PubMed ID: 24245933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents.
    Allen M; Bulte JW; Liepold L; Basu G; Zywicke HA; Frank JA; Young M; Douglas T
    Magn Reson Med; 2005 Oct; 54(4):807-12. PubMed ID: 16155869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
    Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic field dependence of solvent proton relaxation by solute dysprosium (III) complexes.
    Kellar KE; Fossheim SL; Koenig SH
    Invest Radiol; 1998 Nov; 33(11):835-40. PubMed ID: 9818318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis neutral rare earth complexes of diethylenetriamine-N,N''-bis(acetyl-isoniazid)-N,N',N''-triacetic acid as potential contrast enhancement agents for magnetic resonance imaging.
    Zhang DW; Yang ZY; Wang BD; Zhang SP; Yang RD
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1203-6. PubMed ID: 16880671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electronic relaxation of paramagnetic metal ions and NMR relaxivity in solution: critical analysis of various approaches and application to a Gd(III)-based contrast agent.
    Fries PH; Belorizky E
    J Chem Phys; 2005 Sep; 123(12):124510. PubMed ID: 16397947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and magnetic properties of Mn(III) and Cu(II) tetranuclear azido polyoxometalate complexes: multifrequency high-field EPR spectroscopy of Cu4 clusters with S = 1 and S = 2 ground states.
    Mialane P; Duboc C; Marrot J; Rivière E; Dolbecq A; Sécheresse F
    Chemistry; 2006 Feb; 12(7):1950-9. PubMed ID: 16475214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
    Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
    Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
    Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
    Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights on the relaxation of liposomes encapsulating paramagnetic Ln-based complexes.
    Mulas G; Ferrauto G; Dastrù W; Anedda R; Aime S; Terreno E
    Magn Reson Med; 2015 Aug; 74(2):468-73. PubMed ID: 25186276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast visibility for indirect MR arthrography with different protein contents and agent relaxivities at different field strengths: an in vitro model.
    Nouh MR; Schweitzer ME; Ragatte RR
    Eur J Radiol; 2011 Nov; 80(2):559-64. PubMed ID: 21242041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luminomagnetic Eu
    Tesch A; Wenisch C; Herrmann KH; Reichenbach JR; Warncke P; Fischer D; Müller FA
    Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():422-431. PubMed ID: 28887994
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.